These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6240922)

  • 21. Isolation of monoclonal rheumatoid factors in hypergammaglobulinemic purpura.
    Preud'homme JL; Duarte F; Aucouturier P
    Diagn Immunol; 1984; 2(4):219-23. PubMed ID: 6525783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperviscosity retinopathy. A scientific approach to therapy.
    Grindle CF; Buskard NA; Newman DL
    Trans Ophthalmol Soc U K (1962); 1976 Jul; 96(2):216-9. PubMed ID: 827830
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperviscosity syndrome, macroglobulinemia].
    Hatta Y; Sawada U
    Nihon Rinsho; 2004 May; 62 Suppl 5():550-3. PubMed ID: 15197982
    [No Abstract]   [Full Text] [Related]  

  • 24. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The results of 5 years' use of a method for heparin cryoprecipitation of plasma proteins (selective plasmapheresis) in patients with an immune-complex pathology].
    Margulis EIa; Savchenko VG
    Ter Arkh; 1989; 61(7):65-9. PubMed ID: 2531473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperviscosity syndrome in rheumatoid arthritis.
    Baron M; Fam AG; Elkan I; Underdown B
    J Rheumatol; 1982; 9(6):843-9. PubMed ID: 7161774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of plasmapheresis in Waldenström's macroglobulinemia.
    Stone MJ; Bogen SA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Waldenstrom's macrogloblinaemia: modified plasmapheresis as treatment option in a Nigeria setting.
    Abjah UM; Aken'Ova YA; Ocheni S
    Niger J Med; 2002; 11(4):190-2. PubMed ID: 12955999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human monoclonal macroglobulins with antibody activity.
    Stone MJ; McElroy YG; Pestronk A; Reynolds JL; Newman JT; Tong AW
    Semin Oncol; 2003 Apr; 30(2):318-24. PubMed ID: 12720161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of hyperviscosity by apheresis.
    Zarkovic M; Kwaan HC
    Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies. A study in patients with macroglobulinemia.
    Wiedermann D; Wiedermann B; Cídl K; Kodousková V
    Neoplasma; 1980; 27(4):473-81. PubMed ID: 6779211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macroglobulinemia with hyperviscosity syndrome in a dog.
    Hurvitz AI; Haskins SC; Fischer CA
    J Am Vet Med Assoc; 1970 Aug; 157(4):455-60. PubMed ID: 4988780
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.
    Mullen EC; Wang M
    Clin J Oncol Nurs; 2007 Feb; 11(1):87-95. PubMed ID: 17441400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic plasmapheresis--a new form of adjuvant treatment (author's transl)].
    Tilz GP; Teubl I; Kopplhuber C; Vollmann H; Lanzer G
    Med Klin; 1976 Nov; 71(45):1952-7. PubMed ID: 825711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocytotoxic antibodies and intermediate immune complexes in hypergammaglobulinemic purpura of Waldenström.
    Lopez LR; Schocket AL; Carr RI; Kohler PF
    Ann Allergy; 1988 Aug; 61(2):93-6. PubMed ID: 3400906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How we treat Waldenström's macroglobulinemia.
    Dimopoulos MA; Merlini G; Leblond V; Anagnostopoulos A; Alexanian R
    Haematologica; 2005 Jan; 90(1):117-25. PubMed ID: 15642678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.